Compare LBRX & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LBRX | FBIZ |
|---|---|---|
| Founded | 2015 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.6M | 462.2M |
| IPO Year | 2025 | N/A |
| Metric | LBRX | FBIZ |
|---|---|---|
| Price | $23.80 | $58.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $49.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 187.1K | 27.1K |
| Earning Date | 06-25-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | N/A | ★ 14.32 |
| EPS | N/A | ★ 5.94 |
| Revenue | N/A | ★ $159,972,000.00 |
| Revenue This Year | N/A | $15.69 |
| Revenue Next Year | N/A | $8.47 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | N/A | ★ 10.61 |
| 52 Week Low | $13.36 | $42.18 |
| 52 Week High | $24.95 | $60.54 |
| Indicator | LBRX | FBIZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.82 | 57.11 |
| Support Level | $23.52 | $58.75 |
| Resistance Level | $24.84 | $60.16 |
| Average True Range (ATR) | 1.47 | 1.51 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 79.07 | 70.20 |
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.